Delivra Health Brands Inc.
DHBUF
$0.20
$0.000.74%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.93% | 0.81% | 8.66% | 0.19% | 25.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.93% | 0.81% | 8.66% | 0.19% | 25.30% |
| Cost of Revenue | 7.07% | 10.42% | 14.86% | -2.10% | 19.40% |
| Gross Profit | 2.92% | -7.31% | 3.07% | 2.47% | 31.36% |
| SG&A Expenses | 6.51% | 18.02% | 20.69% | 19.80% | 18.06% |
| Depreciation & Amortization | -6.12% | -4.33% | -3.21% | -3.02% | -2.55% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.50% | 12.20% | 15.44% | 6.88% | 16.20% |
| Operating Income | -15.63% | -714.33% | -135.41% | -149.53% | 49.00% |
| Income Before Tax | -233.67% | 86.33% | 101.64% | -62.82% | 531.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -233.67% | 86.33% | 101.64% | -62.82% | 531.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -233.67% | 86.33% | 101.64% | -62.82% | 531.73% |
| EBIT | -15.63% | -714.33% | -135.41% | -149.53% | 49.00% |
| EBITDA | -31.10% | -130.14% | -134.29% | -110.71% | 1,852.55% |
| EPS Basic | -330.83% | 46.70% | 77.78% | -151.20% | 306.90% |
| Normalized Basic EPS | -17.02% | 2.49% | 29.20% | -26.50% | 54.37% |
| EPS Diluted | -330.83% | 46.70% | 77.78% | -174.42% | 189.55% |
| Normalized Diluted EPS | -17.02% | 2.49% | 29.20% | -21.05% | 55.66% |
| Average Basic Shares Outstanding | 1.92% | 21.02% | 28.12% | 25.01% | 20.26% |
| Average Diluted Shares Outstanding | 1.92% | 21.02% | 28.12% | 18.18% | 13.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |